A phase IIIb study of 8-week glecaprevir/pibrentasvir treatment in adults with acute hepatitis C

Journal:

Journal of Hepatology

Published:

2025-11-25

DOI:

10.1016/j.jhep.2025.11.009

Affiliations:

8

Authors:

12

Go to article

Institutions	Authors	Share
AbbVie, United States of America (USA)	6.000000	0.50
Medical University of Vienna (MUW), Austria	1.000000	0.08
Johns Hopkins University (JHU), United States of America (USA)	1.000000	0.08
Germans Trias i Pujol University Hospital (HUGTP), ICS, Spain	1.000000	0.08
University Hospital Bonn (UKB), Uni Bonn, Germany	1.000000	0.08
University of Naples Federico II (UNINA), Italy	1.000000	0.08
University of Milano-Bicocca (UNIMIB), Italy	0.500000	0.04
Niguarda Hospital, Italy	0.500000	0.04

Interested in Medical Microbiology?